Form 4: Definitive Healthcare Corp. Executive Kate Marie Shamsuddin Reports Share Transaction
SEC Form 4 Filing
Kate Marie Shamsuddin, Chief Product Officer of Definitive Healthcare Corp., reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 14, 2024, Kate Marie Shamsuddin, Chief Product Officer of Definitive Healthcare Corp., had 1,044 shares of Class A Common Stock withheld by the issuer to cover tax obligations.
- The price per share for the transaction was $8.09.
- Following the transaction, Shamsuddin directly owns 324,786 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing related to tax obligations, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities, providing investors with insights into the actions of company executives and their confidence in the company's stock.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine tax-related share withholding.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Date of the reported transaction where shares were withheld for tax obligations. |
| 03/18/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.